Patent details

Basic Information

Publication number:

EP2301955

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP101882157

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Varicella Zoster virus vaccine

French Title of Invention:

Vaccin de virus de Varicelle Zoster

German Title of Invention:

Impfstoff gegen das Varicella-Zoster-Virus

SPC Number:

Dates

Filing date:

01/03/2006

Grant date:

18/04/2018

EP Publication Date:

30/03/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/04/2018

EP B1 Publication Date:

18/04/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/03/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/04/2018

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Agent

Name:

KIRKPATRICK

From:

01/06/2018

Address:

Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

Stephenne, Jean

Address:

Belgium (BE)

2

Name:

Hanon, Emmanuel Jules

Address:

Belgium (BE)

Priority

Priority Number:

0504436

Priority Date:

03/03/2005

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 39/25; A61K 39/39; A61P 31/22; C07K 14/04;

Publication

European Patent Bulletin

Issue number:

201816

Publication date:

18/04/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

18/02/2025

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
12/06/2018	Outgoing Correspondence	1
01/06/2018	Power Of Attorney	2